Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Indian Journal of Medical Sciences|October 24, 2003
Socioeconomic burden of nosocomial infectionsAta Nevzat YalcinImmunopharmacology and Immunotoxicology|September 5, 2020
Future perspective: biologic agents in patients with severe COVID-19Arzu Didem Yalcin, Ata Nevzat YalcinImmunopharmacology and Immunotoxicology|July 2, 2020
A case of asthma with Behcet's disease: successful treatment with omalizumab and its effects on recurrent aphthous lesionsArzu Didem Yalcin, Ata Nevzat YalcinImmunopharmacology and Immunotoxicology|April 29, 2016
Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levelsArzu Didem Yalcin, Betul Celik, Ata Nevzat YalcinLe Infezioni in Medicina|August 19, 2004
Antibiotic usage and costs in the communityHalil Karatas, Ata Nevzat Yalcin, Huseyin Turgut, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 2, 2010
Increased mean platelet volume in chronic hepatitis B patients with inactive diseaseOzge Turhan, Erkan Coban, Dilara Inan, et al.Le Infezioni in Medicina|July 16, 2008
Status of influenza vaccination in patients presenting to two neighborhood primary health care clinics in AntalyaSelma Oncel, Ozge Turhan, Polat Hasan Huseyin, et al.Infection Control and Hospital Epidemiology|March 31, 2005
Compliance with hand hygiene and glove use in a university-affiliated hospitalNevin Kuzu, Fadime Ozer, Semra Aydemir, et al.BMC Pulmonary Medicine|April 28, 2004
Costs and risk factors for ventilator-associated pneumonia in a Turkish university hospital's intensive care unit: a case-control studyRiza Hakan Erbay, Ata Nevzat Yalcin, Mehmet Zencir, et al.The American Journal of Case Reports|September 17, 2016
Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse PrednisoloneRusen Uzun, Arzu Didem Yalcin, Betul Celik, et al.Pageof 3